Bronchiectasis  >>  ciprofloxacin (Q3939)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
RESPIRE 1, NCT01764841 / 2011-004208-39: Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Completed
3
416
Japan, US, Europe, RoW
Ciprofloxacin DPI (BAYQ3939), Placebo
Bayer, Novartis
Bronchiectasis
03/16
03/16
RESPIRE 2, NCT02106832 / 2013-004659-19: Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Completed
3
521
US, Europe, RoW
Ciprofloxacin (BAYQ3939) dry powder for inhalation, Placebo
Bayer, Novartis
Bronchiectasis
09/16
10/16

Download Options